A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q1 FY2027, filed Oct 2, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the NKE SEC filings page.
Nike, Inc. (NKE) reported $45.9B in revenue over the twelve months to Aug 31, 2026, down 1.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
NIKE's recent earnings weakness is not a volume story alone: lower margins and weaker cash conversion are reshaping a once cash-rich model.
From FY2024 to FY2026, free-cash-flow margin fell from12.9% to4.7% while revenue ended below FY2024 levels, pointing to weaker cash generation rather than expansionary reinvestment. Accounts receivable rose from$4.4B in FY2024 to$5.9B in FY2026, so more reported sales were tied up in customer balances instead of becoming cash.
Gross margin held near
Debt-to-equity fell from 0.6x to 0.4x by FY2026, making the balance sheet less debt-dependent even as earnings weakened. The current ratio fell from 2.4x to 2.0x, while buybacks contracted and dividends increased, indicating capital returns shifted toward dividends as available cash generation narrowed.
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Nike, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Nike, Inc., and counted as zero in the overall score.
Nike, Inc.'s revenue grew a modest 0.2% year-over-year to $46.4B. This slow but positive growth earns a score of 16/100.
Nike, Inc. has a moderate D/E ratio of 0.40. This balance of debt and equity financing earns a leverage score of 64/100.
Nike, Inc.'s current ratio of 1.96 indicates adequate short-term liquidity, earning a score of 58/100. The company can meet its near-term obligations, though with limited headroom.
Nike, Inc. has a free cash flow margin of 4.7%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.
Not available for Nike, Inc., and counted as zero in the overall score.
Nike, Inc. passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Nike, Inc. generates $0.92 in operating cash flow ($2.9B OCF vs $3.1B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Key Financial Metrics
Earnings & Revenue
Nike, Inc. generated $11.2B in revenue in Q1 2027. This represents a decrease of 4.3% from the same quarter a year earlier. Against the prior quarter it is up 2.2%.
Nike, Inc. reported $712.0M in net income in Q1 2027. This represents a decrease of 2.1% from the same quarter a year earlier. Against the prior quarter it is down 33.4%.
Nike, Inc. earned $0.48 per diluted share (EPS) in Q1 2027. This represents a decrease of 2.0% from the same quarter a year earlier. Against the prior quarter it is down 33.3%.
Not reported for Q1 2027.
Cash & Balance Sheet
Nike, Inc. recorded an outflow of $64.0M in free cash flow in Q1 2027, representing a cash shortfall after capex. This represents a decrease of 526.7% from the same quarter a year earlier. Against the prior quarter it is down 104.3%.
Nike, Inc. held $6.9B in cash against $5.9B in long-term debt as of Q1 2027.
Nike, Inc. paid $0.41 per share in dividends in Q1 2027. This represents an increase of 2.5% from the same quarter a year earlier. It is unchanged from the prior quarter.
Margins & Returns
Nike, Inc.'s gross margin was 42.8% in Q1 2027, indicating the percentage of revenue retained after direct costs. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.4 percentage points.
Nike, Inc.'s net profit margin was 6.3% in Q1 2027, showing the share of revenue converted to profit. This is up 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 3.4 percentage points.
Nike, Inc.'s ROE was 4.7% in Q1 2027, measuring profit generated per dollar of shareholder equity. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 2.5 percentage points.
Not reported for Q1 2027.
Capital Allocation
Nike, Inc. repurchased no shares in Q1 2027. This represents a decrease of 100.0% from the same quarter a year earlier.
Nike, Inc. invested $199.0M in capex in Q1 2027, funding long-term assets and infrastructure. This represents a decrease of 3.9% from the same quarter a year earlier. Against the prior quarter it is up 44.2%.
Not reported for Q1 2027.
NKE Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.2B-4.3% | $11.0B-1.1% | $11.3B+0.1% | $12.4B+0.6% | $11.7B+1.1% | $11.1B-12.0% | $11.3B-9.3% | $12.4B-7.7% |
| Cost of Revenue | $6.4B-5.3% | $5.6B-15.8% | $6.7B+2.4% | $7.4B+6.0% | $6.8B+7.0% | $6.6B-4.9% | $6.6B-4.0% | $7.0B-6.1% |
| Gross Profit | $4.8B-2.9% | $5.4B+20.7% | $4.5B-3.1% | $5.0B-6.4% | $4.9B-6.0% | $4.5B-20.7% | $4.7B-15.9% | $5.4B-9.7% |
| SG&A Expenses | $3.9B-2.6% | $4.1B-1.6% | $4.0B+2.3% | $4.0B+0.8% | $4.0B-0.8% | $4.1B+1.5% | $3.9B-8.0% | $4.0B-3.4% |
| Income Tax | $209.0M+7.2% | $260.0M+143.0% | $130.0M+160.0% | $207.0M-18.2% | $195.0M-23.8% | $107.0M-52.7% | $50.0M-78.4% | $253.0M-26.5% |
| Net Income | $712.0M-2.1% | $1.1B+406.6% | $520.0M-34.5% | $792.0M-31.9% | $727.0M-30.8% | $211.0M-85.9% | $794.0M-32.3% | $1.2B-26.3% |
| EPS (Basic) | $0.48-2.0% | $0.72+380.0% | $0.35-35.2% | $0.54-30.8% | $0.49-30.0% | $0.15-85.0% | $0.54-29.9% | $0.78-25.0% |
| EPS (Diluted) | $0.48-2.0% | $0.72+414.3% | $0.35-35.2% | $0.53-32.1% | $0.49-30.0% | $0.14-85.9% | $0.54-29.9% | $0.78-24.3% |
| Diluted Shares (Avg) | 1.48B+0.4% | N/A | 1.48B+0.1% | 1.48B-0.6% | 1.48B-1.5% | N/A | 1.48B-3.0% | 1.49B-2.7% |
Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA, Interest Expense.
NKE Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $37.8B+1.2% | $38.4B+5.0% | $37.1B-1.9% | $37.8B-0.5% | $37.3B-1.4% | $36.6B-4.0% | $37.8B+1.2% | $38.0B+2.0% |
| Current Assets | $23.7B-0.9% | $24.6B+5.3% | $23.2B-5.8% | $24.0B-3.9% | $23.9B-4.6% | $23.4B-8.0% | $24.6B-0.6% | $25.0B+1.4% |
| Cash & Equivalents | $6.9B-1.7% | $7.6B+1.3% | $6.7B-22.6% | $7.0B-12.6% | $7.0B-17.2% | $7.5B-24.3% | $8.6B-4.0% | $8.0B+0.8% |
| Short-Term Investments | $1.5B-5.5% | $1.5B-13.2% | $1.4B-22.0% | $1.4B-23.1% | $1.6B-14.3% | $1.7B-2.0% | $1.8B+11.1% | $1.8B-11.3% |
| Accounts Receivable | $5.2B+5.6% | $5.9B+25.7% | $5.4B+19.6% | $5.7B+8.2% | $5.0B+4.2% | $4.7B+6.6% | $4.5B-0.8% | $5.3B+10.9% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $240.0M0.0% | $240.0M0.0% | $240.0M+0.4% | $240.0M0.0% | $240.0M0.0% | $240.0M0.0% | $239.0M-0.4% | $240.0M-14.6% |
| Total Liabilities | $22.6B-5.4% | $23.5B+0.8% | $23.0B-3.4% | $23.7B-0.9% | $23.9B-0.2% | $23.4B-1.3% | $23.8B+2.8% | $23.9B+3.8% |
| Current Liabilities | $11.4B+4.6% | $12.5B+18.7% | $10.8B-3.4% | $11.6B+3.5% | $10.9B+2.7% | $10.6B-0.3% | $11.2B+24.3% | $11.2B+25.0% |
| Non-Current Liabilities | $11.2B-13.8% | $11.0B-14.1% | $12.1B-3.4% | $12.1B-4.8% | $13.0B-2.6% | $12.8B-2.2% | $12.6B-10.9% | $12.7B-9.8% |
| Long-Term Debt | $5.9B-26.3% | $5.9B-25.4% | $7.0B-11.6% | $7.0B-12.0% | $8.0B0.0% | $8.0B+0.7% | $8.0B-10.9% | $8.0B-10.7% |
| Total Equity | $15.2B+13.0% | $14.9B+12.5% | $14.1B+0.6% | $14.1B+0.3% | $13.5B-3.4% | $13.2B-8.4% | $14.0B-1.5% | $14.0B-0.8% |
| Retained Earnings | -$56.0M+92.0% | -$155.0M+78.7% | -$610.0M-248.6% | -$519.0M-1061.1% | -$700.0M-270.3% | -$727.0M-175.3% | -$175.0M-118.0% | $54.0M-95.3% |
Not reported in any period shown, so not listed: Inventory.
NKE Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $135.0M-39.2% | $1.6B+253.6% | $430.0M-76.0% | $579.0M-44.8% | $222.0M-43.7% | $463.0M-82.3% | $1.8B-13.0% | $1.0B-62.8% |
| Depreciation & Amortization | $193.0M+1.6% | $193.0M-3.0% | $185.0M-6.6% | $179.0M-5.8% | $190.0M+1.1% | $199.0M-3.9% | $198.0M-4.3% | $190.0M-0.5% |
| Stock-Based Compensation | $158.0M-14.6% | N/A | N/A | N/A | $185.0M+1.1% | N/A | N/A | N/A |
| Capital Expenditures | $199.0M-3.9% | $138.0M+38.0% | $146.0M+80.2% | $193.0M+49.6% | $207.0M+72.5% | $100.0M-53.1% | $81.0M-42.6% | $129.0M-37.1% |
| Free Cash Flow | -$64.0M-526.7% | $1.5B+312.9% | $284.0M-83.4% | $386.0M-58.0% | $15.0M-94.5% | $363.0M-84.9% | $1.7B-10.8% | $920.0M-64.8% |
| Investing Cash Flow | -$192.0M-225.4% | -$212.0M-1614.3% | -$168.0M-242.9% | -$49.0M+33.8% | -$59.0M+64.5% | $14.0M+104.8% | -$49.0M-115.9% | -$74.0M-116.2% |
| Financing Cash Flow | -$618.0M-3.3% | -$514.0M+68.7% | -$601.0M+45.7% | -$579.0M+60.0% | -$598.0M+63.1% | -$1.6B-15.8% | -$1.1B+16.0% | -$1.4B+6.7% |
| Dividends Paid | $610.0M+3.2% | $609.0M+3.0% | $611.0M+2.9% | $611.0M+2.3% | $591.0M+5.9% | $591.0M+5.5% | $594.0M+5.9% | $597.0M+5.7% |
| Share Buybacks | $0-100.0% | $0-100.0% | $0-100.0% | $20.0M-98.2% | $126.0M-89.4% | $199.0M-80.8% | $506.0M-42.7% | $1.1B-8.5% |
NKE Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 42.8%+0.6pp | 49.1%+8.9pp | 40.2%-1.3pp | 40.6%-3.0pp | 42.2%-3.2pp | 40.3%-4.4pp | 41.5%-3.3pp | 43.6%-1.0pp |
| Net Margin | 6.3%+0.2pp | 9.7%+7.8pp | 4.6%-2.4pp | 6.4%-3.0pp | 6.2%-2.9pp | 1.9%-10.0pp | 7.0%-2.4pp | 9.4%-2.4pp |
| Return on Equity | 4.7%-0.7pp | 7.2%+5.6pp | 3.7%-2.0pp | 5.6%-2.7pp | 5.4%-2.1pp | 1.6%-8.8pp | 5.7%-2.6pp | 8.3%-2.9pp |
| Return on Assets | 1.9%-0.1pp | 2.8%+2.2pp | 1.4%-0.7pp | 2.1%-1.0pp | 1.9%-0.8pp | 0.6%-3.4pp | 2.1%-1.0pp | 3.1%-1.2pp |
| Current Ratio | 2.07-0.1x | 1.96-0.3x | 2.14-0.1x | 2.06-0.2x | 2.19-0.2x | 2.21-0.2x | 2.19-0.5x | 2.22-0.5x |
| Debt-to-Equity | 0.39-0.2x | 0.40-0.2x | 0.50-0.1x | 0.50-0.1x | 0.590.0x | 0.60+0.1x | 0.57-0.1x | 0.57-0.1x |
| Asset Turnover | 0.300.0x | 0.290.0x | 0.300.0x | 0.330.0x | 0.310.0x | 0.300.0x | 0.300.0x | 0.330.0x |
| FCF Margin | -0.6%-0.7pp | 13.7%+10.4pp | 2.5%-12.7pp | 3.1%-4.3pp | 0.1%-2.2pp | 3.3%-15.8pp | 15.2%-0.3pp | 7.4%-12.1pp |
Not reported in any period shown, so not listed: Operating Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Nike, Inc. NKE | FY2026 | $46.4B | $3.1B | 6.7% | $55.1B | 32/100 |
| Deckers Outdoor Corp DECK | FY2026 | $5.5B | $1.0B | 18.7% | $11.7B | 82/100 |
| Skechers U.S.A., Inc. SKX | FY2024 | $9.0B | $639.5M | 7.1% | $9.5B | 69/100 |
| Wolverine World Wide, Inc. WWW | FY2025 | $1.9B | $95.8M | 5.1% | $1.6B | 37/100 |
Where Nike, Inc. Ranks
Frequently Asked Questions
What is Nike, Inc.'s annual revenue?
Nike, Inc. (NKE) reported $46.4B in total revenue for fiscal year 2026. This represents a 0.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Nike, Inc.'s revenue growing?
Nike, Inc. (NKE) revenue grew by 0.2% year-over-year, from $46.3B to $46.4B in fiscal year 2026.
Is Nike, Inc. profitable?
Yes, Nike, Inc. (NKE) reported a net income of $3.1B in fiscal year 2026, with a net profit margin of 6.7%.
How much debt does Nike, Inc. have?
As of fiscal year 2026, Nike, Inc. (NKE) had $7.6B in cash and equivalents against $5.9B in long-term debt.
What is Nike, Inc.'s gross margin?
Nike, Inc. (NKE) had a gross margin of 42.9% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Nike, Inc.'s net profit margin?
Nike, Inc. (NKE) had a net profit margin of 6.7% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
Does Nike, Inc. pay dividends?
Yes, Nike, Inc. (NKE) paid $1.63 per share in dividends during fiscal year 2026.
What is Nike, Inc.'s return on equity (ROE)?
Nike, Inc. (NKE) has a return on equity of 20.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Nike, Inc.'s free cash flow?
Nike, Inc. (NKE) generated $2.2B in free cash flow during fiscal year 2026. This represents a -33.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Nike, Inc.'s operating cash flow?
Nike, Inc. (NKE) generated $2.9B in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Nike, Inc.'s total assets?
Nike, Inc. (NKE) had $38.4B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Nike, Inc.'s capital expenditures?
Nike, Inc. (NKE) invested $684.0M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is Nike, Inc.'s current ratio?
Nike, Inc. (NKE) had a current ratio of 1.96 as of fiscal year 2026, which is generally considered healthy.
What is Nike, Inc.'s debt-to-equity ratio?
Nike, Inc. (NKE) had a debt-to-equity ratio of 0.40 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Nike, Inc.'s return on assets (ROA)?
Nike, Inc. (NKE) had a return on assets of 8.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Nike, Inc.'s P/E ratio?
Nike, Inc. (NKE) trades at 17.8x earnings, its market capitalization divided by net income of $3.1B net income, trailing 12 months to August 31, 2026. The market capitalization is $55.1B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Nike, Inc.'s price-to-sales ratio?
Nike, Inc. (NKE) trades at 1.2x sales, its market capitalization divided by revenue of $45.9B revenue, trailing 12 months to August 31, 2026. The market capitalization is $55.1B as of Oct 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Nike, Inc.'s Piotroski F-Score?
Nike, Inc. (NKE) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Nike, Inc.'s earnings high quality?
Nike, Inc. (NKE) has an earnings quality ratio of 0.92x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Nike, Inc.?
Nike, Inc. (NKE) scores 32 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.